Analysis

  • Draper Q&A: upgrading CAR-T therapy manufacturing

    Draper is seeking to update the manufacturing processes and technology used for CAR-T cancer therapies to improve the efficiency and access. The company’s head of precision medicine and cell bioprocessing...

  • August’s top news stories

    Bayer has signed an agreement to acquire US-based biotechnology company BlueRock Therapeutics for $1bn, and The World Health Organization (WHO) has claimed that malaria can be eradicated with accelerated research...

  • Treating SMA: moving beyond genetic approaches

    As a result of dedicated efforts by the pharma industry, there are now two drugs approved for SMA: Spinraza and Zolgensma. Although these have been life-changing for patients with this...

Close
Close
Close

Go Top